Literature DB >> 34177243

Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy.

Christopher James Little1, Bao Sean Nguyen1, Pamela J Tsing1.   

Abstract

A 40-year-old man with stage IV gastric adenocarcinoma was found to have coronary artery vasospasm in the setting of recent 5-fluorouracil administration.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID: 34177243      PMCID: PMC8223732          DOI: 10.12788/fp.0123

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  15 in total

1.  Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.

Authors:  Søren Astrup Jensen; Jens Benn Sørensen
Journal:  Cancer Chemother Pharmacol       Date:  2006-01-18       Impact factor: 3.333

Review 2.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

3.  Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.

Authors:  R M Hansen; L Ryan; T Anderson; B Krzywda; E Quebbeman; A Benson; D G Haller; D C Tormey
Journal:  J Natl Cancer Inst       Date:  1996-05-15       Impact factor: 13.506

4.  Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.

Authors:  Nezih Meydan; Isil Kundak; Tugba Yavuzsen; Ilhan Oztop; Sabri Barutca; Ugur Yilmaz; Mehmet Niyazi Alakavuklar
Journal:  Jpn J Clin Oncol       Date:  2005-04-26       Impact factor: 3.019

5.  5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.

Authors:  B Patel; R A Kloner; J Ensley; M Al-Sarraf; J Kish; J Wynne
Journal:  Am J Med Sci       Date:  1987-10       Impact factor: 2.378

6.  Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.

Authors:  G Akpek; K L Hartshorn
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

7.  5-fluorouracil-induced coronary vasospasm.

Authors:  Laura K Shoemaker; Umesh Arora; Caio M Rocha Lima
Journal:  Cancer Control       Date:  2004 Jan-Feb       Impact factor: 3.302

Review 8.  Fluoropyrimidine-associated cardiotoxicity: revisited.

Authors:  M Wasif Saif; Manasi M Shah; Anuj R Shah
Journal:  Expert Opin Drug Saf       Date:  2009-03       Impact factor: 4.250

Review 9.  5-fluorouracil and cardiotoxicity: a review.

Authors:  Jaskanwal D Sara; Jasvinder Kaur; Ryan Khodadadi; Muneeb Rehman; Ronstan Lobo; Sakti Chakrabarti; Joerg Herrmann; Amir Lerman; Axel Grothey
Journal:  Ther Adv Med Oncol       Date:  2018-06-18       Impact factor: 8.168

Review 10.  Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina.

Authors:  M A Beijk; W V Vlastra; R Delewi; T P van de Hoef; S M Boekholdt; K D Sjauw; J J Piek
Journal:  Neth Heart J       Date:  2019-05       Impact factor: 2.380

View more
  1 in total

1.  Capecitabine-Associated Coronary Vasospasm and Cardiac Arrest.

Authors:  Erind Muco; Haris Patail; Ayesha Shaik; Sean McMahon
Journal:  Cureus       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.